This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Voltaren/XR

Novartis AG

Drug Names(s): diclofenac sodium

Description: BioMedTracker has separate drug profiles for the oral and topical formulations of Voltaren. Please also see Voltaren Gel.

Voltaren is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. The major mechanism of action of NSAIDS is believed to be inhibition of cycloxygenase activity and prostaglandin synthesis.

The XR formulation is given once-daily.


Voltaren/XR News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug